Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-120089
Filing Date
2025-12-10
Accepted
2025-12-10 16:15:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6146
  Complete submission text file 0001213900-25-120089.txt   7773
Mailing Address 20 RAOUL WALENBERG ST TEL AVIV L3 6971916
Business Address 20 RAOUL WALENBERG ST TEL AVIV L3 6971916 972-3-7175777
L.I.A. Pure Capital Ltd (Filed by) CIK: 0001749628 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A

Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Subject) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93839 | Film No.: 251562161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)